Mounjaro (tirzepatide): NICE approved tirzepatide for weight management in early 2025 (TA1026), and NHS prescribing through primary care began in June 2025 as part of a phased 12-year rollout
It found half (51 per cent) of employers said they cover the medications only for diabetes, down from 56 per cent last year and 66 per cent in 2024
Patients who implement structured maintenance strategies , including gradual tapering, exercise, dietary habits, and monitoring, retain more of their weight loss than those who stop abruptly
Peptide therapy at our clinic uses different peptides (e.g
Its about providing care that can improve their lives. Moving toward medications In a dramatic shift in pediatric weight-loss options, the Food and Drug Administration approved a GLP-1 medication the daily injectable liraglutide for kids 12 and up in 2020, and a second the weekly injectable semaglutide in 2022
Glutathione supplementation requires daily consistency for 8-12 weeks before visible skin changes appear
